Oculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference Call Jun 2, 2016
Oculus Innovative Sciences to Present at Pioneers 2016 Investor Conference Hosted by Joseph Gunnar & Company in New York City Apr 28, 2016
Oculus Innovative Sciences to Present at the Third Annual Growth Capital Expo MicroCap Investor Conference in Las Vegas Apr 27, 2016
Oculus Innovative Sciences Receives U.S. FDA Approval for Lasercyn™ for Use Following Laser Procedures, Microdermabrasions and Chemical Peels Apr 20, 2016
Oculus Innovative Sciences Receives European Approval to Market Sinudox™ Indicated for Use in Nasal Irrigation Apr 13, 2016
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Allowance of New Patents for Microcyn® Technology Apr 6, 2016
Oculus Innovative Sciences and Lipogrid of Sweden Announce Strategic Collaboration for Topical Dermatology Drug Delivery Mar 30, 2016
Oculus Innovative Sciences Announces Multi-Year Licensing Agreement with Manna Pro Products, LLC, for MicrocynAH® Animal Healthcare Products Mar 23, 2016
